Advertisement

Topics

Verona Pharma Appoints Dr. Desiree Luthman as Vice President of Regulatory Affairs

07:16 EDT 22 Jun 2017 | FinanzNachrichten

LONDON, June 22, 2017 (GLOBE NEWSWIRE) -- Verona Pharma plc (AIM:VRP) (NASDAQ:VRNA) ('Verona Pharma'), a clinical-stage biopharmaceutical company focused on developing and commercializing innovati...

Original Article: Verona Pharma Appoints Dr. Desiree Luthman as Vice President of Regulatory Affairs

NEXT ARTICLE

More From BioPortfolio on "Verona Pharma Appoints Dr. Desiree Luthman as Vice President of Regulatory Affairs"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Biopharmaceuticals
Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...